Significantly higher than the U.S. national average of 10.5% in 2023.
Key Takeaways
- Alaska's childhood ADHD diagnosis rate of 14.8% is notably higher than the national average of 10.5%.14.8%[2]
- Significant barriers to care exist, with 28% of Alaska's population living in areas underserved by mental health professionals.28%[4]
- The state has only 2 ADHD-specialized providers per 100,000 children, less than half the national average of 5 per 100,000.2 per 100k[3]
- A significant treatment gap exists, with nearly one-third of children with a current ADHD diagnosis receiving no specific treatment.30.1%[1]
- Boys in Alaska are diagnosed with ADHD at a much higher rate (15%) than girls (9%), mirroring national gender disparities.15% vs 9%[1]
- Nationally, more than three-quarters of children with current ADHD have at least one co-occurring mental, emotional, or developmental disorder.77.9%[1]
ADHD Prevalence in Alaska: A Closer Look
Attention-Deficit/Hyperactivity Disorder (ADHD) is a significant public health consideration in Alaska, with diagnosis rates among children trending near the upper end of national estimates[3]. Understanding the prevalence of ADHD across different age groups in the state is the first step toward identifying needs and addressing gaps in care. The following statistics provide a snapshot of how many children and adults in Alaska are affected by ADHD, alongside national data for crucial context.
While various surveys report slightly different figures, with some suggesting a childhood prevalence between 8-9%[3], the most recent data indicates a higher rate. It's important to note that adult ADHD is often underdiagnosed compared to childhood ADHD, meaning the true prevalence among adults may be higher than current data suggests[5].
Based on parent reports for children ages 4-17.
Based on a 2021 NIMH survey of 3,000 Alaskans.
Represents approximately 7.1 million children aged 3-17.
Represents approximately 15.5 million adults.
Adult Attention-Deficit/Hyperactivity Disorder (ADHD)
Source: Data and Statistics on ADHD - CDC. Centers for Disease Control and Prevention. Published 2022. Accessed January 2026. https://www.cdc.gov/adhd/data/index.html
Demographic Differences in ADHD Diagnosis
ADHD does not affect all populations equally. In Alaska and across the nation, significant disparities exist based on gender, race, and ethnicity. Boys are consistently diagnosed at higher rates than girls, a trend that holds true within Alaska[3]. This may be due to differences in symptom presentation, with girls often exhibiting less disruptive, inattentive symptoms that can be overlooked, leading to underdiagnosis and unmet needs[1].
Racial and ethnic disparities are also evident, potentially influenced by cultural perceptions of symptoms, access to care, and systemic biases in assessment methods[8]. Furthermore, national data shows that rural areas report a higher prevalence of ADHD diagnoses compared to urban centers, a particularly relevant factor for a state as vast and rural as Alaska[1].
ADHD Disparities in Alaska
National Context: ADHD Prevalence by Age and Race
To better understand the situation in Alaska, it is helpful to examine national demographic data. Across the United States, the prevalence of an ADHD diagnosis changes significantly with age, peaking during the adolescent years. This highlights the importance of early screening and continued support through middle and high school.
National data also reveals stark differences in diagnosis rates among various racial and ethnic groups. These disparities underscore the need for culturally competent healthcare and equitable access to diagnostic services for all children. The table below details the lifetime prevalence of ADHD diagnosis for key demographic groups nationwide.
Access to ADHD Care and Treatment in Alaska
Accessing diagnosis and treatment for ADHD in Alaska presents unique and formidable challenges. The state's vast geographic isolation, combined with a significant shortage of specialized mental health professionals and persistent stigma, creates major barriers to care[11]. As a result, families often report that wait times for diagnosis and treatment can extend up to six months[3]. The entire state has been designated as a Health Professional Shortage Area (HPSA) for mental health, highlighting the severity of the issue[12].
These challenges are reflected in the data on provider density and insurance coverage. Children with public insurance often face additional difficulties obtaining comprehensive evaluations from subspecialists[3], and even adults with prescriptions can struggle, with nearly 72% nationally reporting difficulty filling stimulant medications[7].
Barriers to Care: By the Numbers
This represents 28% of the state's total population.
These shortage areas are spread across 24 counties in Alaska.
This rate is slightly below the national average of around 70%.
This is slightly lower than the national rate of 82%.
The Treatment Landscape for ADHD
When care is accessible, treatment for ADHD typically involves medication, behavioral therapy, or a combination of both. In Anchorage, available options for adults include medication management, Cognitive Behavioral Therapy (CBT), and integrated care models[16]. Some providers are also adopting a strength-based approach, focusing on a client's innate talents rather than solely on deficits[17].
Despite these options, a significant portion of diagnosed children in Alaska do not receive the recommended care. While many children are prescribed medication soon after diagnosis[3], access to behavioral therapy—the recommended first-line treatment for preschool-age children—can be limited[3]. This treatment gap exposes children to long-term academic and social challenges[3].
ADHD Treatment Rates in Alaska vs. U.S.
This means nearly one-third of diagnosed children receive no treatment.
Centers for Disease Control and Prevention (2020)This rate is identical to the national average for medication use.
Centers for Disease Control and Prevention (2016)This is consistent with the national rate, though national trends show minority children are less likely to receive this therapy.
Centers for Disease Control and Prevention (2016)The Role of Telehealth and Policy
Outcomes and Co-occurring Conditions
Early and accurate diagnosis of ADHD is critical because when left untreated, it can lead to a cascade of co-occurring conditions, from behavioral disorders to mood disturbances[3]. The high rate of comorbidity underscores the complexity of ADHD and the need for comprehensive, integrated care that addresses a person's full range of mental health needs.
While direct data on ADHD's link to suicide in Alaska is limited, the state's overall mental health landscape is concerning. Alaska's suicide rate is alarmingly high, and a significant portion of the adult population lives with a mental illness. These statistics highlight the urgent need for accessible and effective mental health services across the state.
This is nearly three times higher than the U.S. national average of 14 per 100,000.
This includes conditions like depression, anxiety, and others that can co-occur with ADHD.
Economic Impact of ADHD Care
The financial aspects of ADHD care create another significant barrier for many Alaskans. The direct costs of obtaining a diagnosis can be prohibitively expensive, with assessments sometimes exceeding $1,000 per appointment[3]. These high out-of-pocket expenses can delay or prevent individuals from seeking the help they need.
On a systemic level, state funding for mental health services also plays a crucial role. Alaska's per capita spending on mental health is below the national average, which can impact the availability and quality of public programs and support systems for individuals with ADHD and other mental health conditions.
Mental Health Funding: Alaska vs. National Average
Trends in ADHD Diagnosis Over Time
ADHD diagnosis rates are not static; they evolve over time due to changes in public awareness, diagnostic practices, and access to care. In Alaska, there has been an incremental rise in childhood ADHD diagnoses in recent years. Between the 2016-2019 and 2020-2023 periods, the prevalence saw a 1.5 percentage point increase[1].
National trends have also shown dynamic changes, particularly around the COVID-19 pandemic. Adult diagnosis rates decreased from 2016 to 2020 before rising significantly through 2023[7]. Conversely, adolescent diagnosis rates declined sharply between 2016 and 2018 before stabilizing[7]. These shifts highlight the complex factors influencing when and how ADHD is identified.
Frequently Asked Questions
Sources & References
All statistics and claims on this page are supported by peer-reviewed research and official government data sources.
